Assertio Therapeutics Inc (ASRT)

NASDAQ
1.63
-0.08(-4.68%)
After Hours
1.66
+0.03(+1.84%)
- Real-time Data
  • Volume:
    694,119
  • Bid/Ask:
    1.65/1.66
  • Day's Range:
    1.625 - 1.72

ASRT Overview

Prev. Close
1.71
Day's Range
1.625-1.72
Revenue
112.2M
Open
1.68
52 wk Range
1.32-5.8
EPS
-2.45
Volume
694,119
Market Cap
70.82M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,773,297
P/E Ratio
-
Beta
1.52
1-Year Change
-51.77%
Shares Outstanding
43,447,149
Next Earnings Date
Aug 11, 2021
What is your sentiment on Assertio Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Assertio Therapeutics Inc News

Assertio Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellNeutral
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellStrong SellNeutral

Assertio Therapeutics Inc Company Profile

Assertio Therapeutics Inc Company Profile

Employees
27

Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Suspension, INDOCIN (indomethacin) Suppositories, OXAYDO tablets, SPRIX Nasal Spray, VIVLODEX capsules, ZIPSOR Liquid filled capsules and ZORVOLEX capsules. The Company is also focused on developing and commercializing neurology, orphan and specialty medicines. Its pipeline products include Diclofenac Potassium, Long-acting Cosyntropin and Diclofenac potassium. Diclofenac Potassium is being developed for mild/moderate acute pain. Long-acting Cosyntropin is being developed for diagnosis of adrenal insufficiency. Diclofenac potassium is a liquid formulation being developed for acute migraine attacks.

Read More
  • buy at 3 best price
    0
    • Who did allow to do reverse split? I didnt definitely, awfull mgt. direct offering, price droped badly direct after that - reverse split. No need for mgt to work or do their job properly!
      0
      • 🚶🏾‍♂️
        0
        • On June 4, 2021, Assertio Holdings, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company has regained compliance with Nasdaq’s minimum bid price requirement under Rule 5550(a)(2) of the Nasdaq Listing Rules for continued listing on The Nasdaq Capital Market, and the matter is now closed.
          1
          • ASRT will not be delisted
            0
          • Jordane Taelmanits bad news innsnyway
            0
        • I hope this is sustainable
          1
          • Yea. 4 is possible. It may take some days and some lows though. I hope it repeats the cycle of its last boom.
            0
          • Jordane Taelman4 in how many time?
            0
          • 1 month
            0
        • m'han robat
          0
          • Everybody so bearish :(
            0
            • its split 4 to 1
              0
              • shalom))))
                0
            • Thank u antonis theofilou
              0
              • Yes its real
                1
                • Please can tail me this is split real??
                  0
                  • estoupou
                    0
                    • Levouna o de mo
                      0
                  • What? 😳
                    0
                    • Asrt unfortunately is going to reverse split 1-4
                      0
                      • Any clue on what could drive a surge?
                        0
                    • the longer the lows, the higher the peak...
                      0
                      • What's driving this downturn?
                        0
                        • Això esta carregant per disparar a 1,5 $
                          1
                          • hora de volar
                            0
                        • buy before we fly.all good news here
                          0
                          • Big short candle...
                            0
                            • Back to 1$
                              0
                              • will be a huge gap up.
                                0
                                • What happened? After hour +42%? Any news ?
                                  0
                                  • Earnings
                                    0
                                • Not sure, that we'll see good news...
                                  0
                                  • Today results
                                    0
                                    • when out of nasdaq for being under 1$?
                                      0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.